0001827506-24-000055.txt : 20240607
0001827506-24-000055.hdr.sgml : 20240607
20240607160311
ACCESSION NUMBER: 0001827506-24-000055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCDADE MARK
CENTRAL INDEX KEY: 0001242126
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40384
FILM NUMBER: 241029212
MAIL ADDRESS:
STREET 1: C/O PROTINE DESIGN LAB
STREET 2: 7442 NORTH MARCER WAY
CITY: MERCER ISLAND
STATE: WA
ZIP: 98040
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tourmaline Bio, Inc.
CENTRAL INDEX KEY: 0001827506
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27 WEST 24TH STREET
STREET 2: SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 646-481-9832
MAIL ADDRESS:
STREET 1: 27 WEST 24TH STREET
STREET 2: SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10010
FORMER COMPANY:
FORMER CONFORMED NAME: Talaris Therapeutics, Inc.
DATE OF NAME CHANGE: 20201007
4
1
wk-form4_1717790581.xml
FORM 4
X0508
4
2024-06-05
0
0001827506
Tourmaline Bio, Inc.
TRML
0001242126
MCDADE MARK
C/O QIMING U.S. VENTURES MANAGEMENT, LLC
11100 NE 8TH ST., SUITE 200
BELLEVUE
WA
98004
1
0
0
0
0
Stock Option (Right to Buy)
13.91
2024-06-05
4
A
0
10000
0
A
2034-06-04
Common Stock
10000
10000
D
100% of the shares subject to the option vest on the earlier of the anniversary of the Transaction Date or the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on such vesting date.
/s/ Brad Middlekauff, Attorney-in-Fact
2024-06-07